NotesFAQContact Us
Collection
Advanced
Search Tips
Peer reviewed Peer reviewed
Direct linkDirect link
ERIC Number: EJ1136490
Record Type: Journal
Publication Date: 2017-Mar
Pages: 8
Abstractor: As Provided
ISBN: N/A
ISSN: ISSN-0021-9584
EISSN: N/A
Using an in Silico Approach to Teach 3D Pharmacodynamics of the Drug-Target Interaction Process Focusing on Selective COX2 Inhibition by Celecoxib
Tavares, MaurĂ­cio T.; Primi, Marina C.; Silva, Nuno A. T. F.; Carvalho, Camila F.; Cunha, Micael R.; Parise-Filho, Roberto
Journal of Chemical Education, v94 n3 p380-387 Mar 2017
Teaching the molecular aspects of drug-target interactions and selectivity is not always an easy task. In this context, the use of alternative and engaging approaches could help pharmacy and chemistry students better understand this important topic of medicinal chemistry. Herein a 4 h practical exercise that uses freely available software as a tool to teach the drug-target interaction process is described. This exercise is designed as a comparative approach based on the distinct cyclooxygenase 2 (COX2) affinities of ibuprofen and celecoxib. Students learn how to find crystallographic structures in free protein databases online and how to treat the raw crystallographic data. Thus, students learn how to analyze the drug arrangement on the active site, looking for areas that are related to the molecular recognition process. At the end of the class, students summarize all of the molecular requirements related to drug-target interactions and selectivity. Additionally, students visualize three-dimensionally the structure-activity relationship of ibuprofen and celecoxib.
Division of Chemical Education, Inc and ACS Publications Division of the American Chemical Society. 1155 Sixteenth Street NW, Washington, DC 20036. Tel: 800-227-5558; Tel: 202-872-4600; e-mail: eic@jce.acs.org; Web site: http://pubs.acs.org/jchemeduc
Publication Type: Journal Articles; Reports - Descriptive
Education Level: Higher Education; Postsecondary Education
Audience: N/A
Language: English
Sponsor: N/A
Authoring Institution: N/A
Grant or Contract Numbers: N/A